autologous adoptive lymphocyte cell therapy (Beijing Biohealthcare Biotechnology)

N/A

Report date: 2025/03/14 16:46:01

Base Information

Drug Nameautologous adoptive lymphocyte cell therapy (Beijing Biohealthcare Biotechnology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapyCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Biohealthcare Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Biohealthcare Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A